Primary assessment of medicines for expected migrastatic potential with holographic incoherent quantitative phase imaging.

Suránová, Markéta; Duris, Miroslav; Stenglová Netíková, Irena; Brábek, Jan; Horák, Tomás; Juzová, Veronika; Chmelík, Radim; Veselý, Pavel.

Afiliação

Suránová M; Institute of Physical Engineering (IPE), Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic.
Duris M; CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Stenglová Netíková I; CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Brábek J; General University Hospital in Prague, Department of Clinical Pharmacology and Pharmacy, Prague, Czech Republic.
Horák T; Department of Cell Biology, and Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV), Laboratory of Cancer Cell Invasion, Charles University, Prague, Czech Republic.
Juzová V; Institute of Physical Engineering (IPE), Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic.
Chmelík R; CEITEC - Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Veselý P; Institute of Physical Engineering (IPE), Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic.

Biomed Opt Express ; 14(6): 2689-2708, 2023 Jun 01.

Article em En | MEDLINE | ID: mdl-37342686

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article